Abstract
Introduction
Primary progressive aphasia (PPA) refers to three primary clinical variants: semantic (svPPA), non-fluent (nfvPPA), and logopenic variant (lvPPA). SvPPA patients maintain fluent speech but have severe impairments in expressive and receptive single-word comprehension, which impair recognition of objects and people. In contrast, communication in nfvPPA involves effortful, halting speech with grammatical and speech production errors leading to non-fluent communication. lvPPA has a distinct pattern of speech disruption with overlaps with nfvPPA; however, in contrast to svPPA and nfvPPA is primarily pathologically associated with Alzheimer's disease [1] [2] [3] .
In PPA, assessment of language often outweighs assessment of functional disability. Functional deficits are defined as disability in activities of daily living (ADLs), comprising change in a number of daily tasks of varying levels of complexity [4] . Current diagnostic criteria for PPA state that ADLs are relatively well maintained during the initial phase of the condition [1, 5] . Over time, however, PPA becomes similar to all dementia syndromes, where localized language and cognitive dysfunction evolves into generalized dementia affecting multiple functional domains and leading to care facility placement.
Recently, it has been described that decline in everyday function in LPA is initially limited to instrumental ADLs, in contrast to nfvPPA which shows more generalized decline across both basic and instrumental ADLs [6] . Similarly, longitudinal functional changes may be more marked in nfvPPA than in svPPA, but the factors behind these are not well known [7] [8] [9] [10] . While the relationship between behavioural symptoms and functional decline in LPA and nfvPPA has been compared, this relationship is yet to be understood in nfvPPA in comparison to svPPA, which is particularly intriguing in light of unremarkable behavioural changes in nfvPPA.
This study aimed to (1) characterize functional deficits in svPPA and nfvPPA; (2) examine longitudinal functional deficits in relation to cognitive and behavioural symptoms; (3) identify predictors of functional disability in svPPA and nfvPPA over a 12-month period.
Methods

Participants
Twenty-nine participants (svPPA = 18; nfvPPA = 11) were consecutively recruited via convenience sampling from the FRONTIER Research Group in Sydney, and assessed either in the clinic, home or care facility on two separate occasions approximately 1 year apart (mean = 1.4 years ± 0.6) between November 2007 and December 2011. A total of 114 functional and behavioural assessments were completed across the 29 participants over the study time period and included for the analyses. Participants were included at baseline if (1) they fulfilled current criteria for svPPA or nfvPPA [1] ; (2) had a reliable proxy informant to report on everyday functioning and behaviour (informants were judged reliable if they either lived with or regularly saw the patient, and if they were able to clearly articulate functional and behavioural information pertaining to the patient); (3) did not have any major physical impairment such as requiring mobility aids; (4) did not have major depressive symptoms as measured by the DASS-21 [11, 12] , and (5) had a longitudinal assessment within 18 months. People with a diagnosis of lvPPA were excluded from this study based on a combination of a neurological clinical assessment, neuropsychological data and in vivo β-amyloid imaging. Of note, in the nfvPPA group, 2/11 participants were later re-diagnosed with atypical Parkinsonian syndromes (corticobasal syndrome, CBS, or progressive supranuclear palsy, PSP). Due to the already small participant numbers in this study, these participants were retained for the analyses. Finally, 7/11 from the nfvPPA subgroup, and 8/18 in the svPPA subgroup have died since this study was conducted.
A multidisciplinary consensus based on a neurological clinical assessment (J.R.H.) and a comprehensive neuropsychological battery were used for the diagnosis. Estimated disease duration was calculated at the time of diagnosis based on the reported onset of symptoms by the informant.
Instruments
Functional Assessment
The Disability Assessment for Dementia (DAD) was used to assess the level of functioning in ADLs [13] . The DAD is an informant-based measure evaluating 23 instrumental ADLs (IADLs) and 17 basic self-care ADLs (BADLs) and has been extensively used in frontotemporal dementia (FTD) studies [7, 9, 14] . IADL domains include: 'meal preparation', 'telephoning', 'going on an outing', 'finance and correspondence', 'medications', and 'leisure and housework'; BADL domains evaluate 'hygiene', 'dressing', 'continence', and 'eating'. Questions that are not applicable are excluded to avoid activity bias (e.g. finances; cooking). Total DAD score is reported as a percentage of remaining ability, where lower scores represent greater impairment.
In order to further distinguish clinical differences between subgroups, total DAD, BADL and IADL subscores were included in the analysis. All caregivers were interviewed by experienced research occupational therapists (E.M., C.M.O.C. or C.K.) at baseline and follow-up visits.
Behavioural Assessment
The Cambridge Behavioural Inventory Revised (CBI-R) is a caregiver-based assessment that measures and discriminates behaviour across ten domains [15] . For each of the 45 items, the caregiver is required to rate behavioural changes on a 4-point scale (0 = never, 1 = a few times per month, 2 = a few times per week, 3 = daily, and 4 = constantly), where higher scores indicate higher frequency of abnormal behaviours.
Given the FTD focus on this study, only four domains were included: 'memory and orientation', 'abnormal behaviour/disinhibition', 'stereotypic and motor behaviours', and 'apathy' [16] . Two people with svPPA did not have complete baseline and follow-up assessments.
Brief Cognitive Assessment A brief screening tool sensitive to the early stages of dementia was used at baseline. The Addenbrooke's Cognitive Examination Revised (ACE-R) assesses five cognitive domains: 'attention and orientation', 'memory', 'verbal fluency', 'language', and 'visuospatial' abilities [17] . Total score is 100, where higher scores reflect greater cognitive ability. The 88/100 cut off yields 94% sensitivity and 89% specificity for diagnosing dementia, and the tool has been reported as useful in tracking PPA progression [18] .
Data Analyses
Data were analyzed using the Statistical Package for Social Sciences 21.0 (SPSS). Participants were categorized according to length of symptoms at baseline. Two categories were created: 'early stage' referred to disease duration of less than 5 years; 'moderate stage' participants had 5 or more years of disease. The 5-year cut-off was used in this sample for two reasons: firstly, all recruited svPPA patients [5] already had a disease duration longer than 2 years by the time they presented at the clinic for their baseline visit. Secondly, many patients from both the svPPA and nfvPPA subgroups were still managing a majority of their ADLs despite having at least 5 years of disease duration. Therefore a 5-year cut-off was deemed more suitable to represent 'moderate stage' for this study. The baseline analyses (functional deficits and behavioural changes) focused on the early stage (svPPA, n = 11/18; nfvPPA, n = 11/11). The longitudinal analyses and the linear regression analysis included all participants. Of note, all moderate-stage participants belonged to the svPPA group.
Demographic data were analyzed using parametric independent-samples t tests. KolmogorovSmirnov tests were used to determine the normality of distribution of the main variables of interest at baseline, and non-parametric measures were used to take into account the skewness of the data distribution in some of these variables. Mann-Whitney U tests were performed to analyze dementia subgroup differences within the 'early' stages with regard to functional deficits and behavioural change. At follow-up, all variables of interest were normally distributed. Repeated-measures ANOVA were used to investigate the effect of diagnosis and time on total DAD, IADLs and BADLs scores. For these longitudinal analyses, diagnostic subgroups were analyzed as a whole (svPPA = 18/18; nfvPPA = 11/11) for more appropriate statistical inferences.
In order to investigate which baseline scores could predict the annual rate of change in functional scores, a forced entry multiple regression using the Enter method was performed for both the svPPA and nfvPPA subgroups. A forward sequential regression approach was used to conserve power given the small sample size. The annual rate of change in function was calculated by subtracting the follow-up total DAD score from the baseline total DAD score for each participant. The annual rate of change was used as the dependent variable, with five baseline scores used as independent variables. The choice of these variables was largely based on the differences between diagnostic groups at baseline: ACE-R, CBI-R memory score; CBI-R stereotypical behaviour score; CBI-R apathy score; DAD total score. A series of regressions were run using differing block variations of entering variables to estimate the best model for predicting the annual rate of change.
Results
Demographics
There were no differences observed between svPPA and nfvPPA for age or total years of education at baseline (all ps > 0.05; table 1 ). The length of symptoms was significantly longer for svPPA (p < 0.0001), whereas ACE-R scores were higher for nfvPPA (p < 0.05). Notably, 3/18 (16.7%) of svPPA patients had predominantly right-sided temporal atrophy, and 2/11 (18.2%) of nfvPPA patients had apraxia of speech.
Functional Status at Baseline Assessments (First Visit to Research Institute)
In the svPPA subgroup, 11/18 participants were in the 'early stage', as defined by up to 5 years of disease duration, whereas all participants with a diagnosis of nfvPPA were included in the 'early stage' category due to their shorter length of history ( table 1 ) .
Overall ADL function was similar between svPPA and nfvPPA, as shown by the DAD total score ( fig. 1 a) . When these scores were broken down into more complex instrumental ( fig. 1 b) and basic ADLs ( fig. 1 c) , the similarity between groups remained. Interestingly, the outlier participant (very low functional scores) from the nfvPPA group in each of these figures went on to later develop an atypical Parkinsonian syndrome (CBS) ( fig. 1 ) .
Behavioural Changes at Baseline
In parallel to functional disability, we also explored behavioural differences between the two PPA groups according to the duration of their symptoms since disease onset, in order to understand their potential contribution to ADL dysfunction. Early in the disease ('early stage'), svPPA scored significantly higher in memory impairment than nfvPPA (U = 15, z = -2.829, p < 0.005). Higher levels of stereotypical behaviour (U = 26.5, z = -2.035, p < 0.05), and apathy (U = 20.5, z = -2.439, p < 0.05) were also found in svPPA. The differences between both groups were substantial across these two domains, with 60% of patients from the svPPA group showing marked deficits, compared with only 9% of patients from the nfvPPA group. Lastly, there were no significant differences for disinhibition scores between the PPA groups, with both groups demonstrating mild-moderate degree of changes. Interestingly, patients with nfvPPA who went on to develop an atypical Parkinsonian syndrome (CBS or PSP) tended to demonstrate higher scores on behavioural dysfunction at baseline ( fig. 2 ) . 
Longitudinal Functional Decline
On average, follow-up assessments were conducted 1 year apart (mean = 1.4 years ± 0.6). Repeated-measures ANOVA revealed an effect of time for total DAD score, and IADL and BADL scores for both svPPA and nfvPPA. Critically, there were no interactions between time and diagnoses on any of these three analyses, confirming that both diagnostic groups showed similar decline on these three scores at the follow-up visit ( fig. 3 ).
What Factors Can Predict Functional Scores at Follow-Up? For svPPA, a model trend emerged from the multiple regression for the annual rate of change in functional (DAD) scores (F (13) = 3.71, p = 0.05) consisting of (a) total DAD score at baseline, and (b) ACE-R score at baseline. This model explained 36.4% of the variance of the annual rate of change in functional scores (p < 0.05) ( table 2 ), with most of the variance (35.5%) explained by the ACE-R score at baseline. Other models in this regression, containing forward sequentially added scores for apathy, stereotypical behaviour, and memory deficits in separate blocks were not significant. For nfvPPA, a significant model to predict the annual rate of change in functional scores emerged from the multiple regression consisting of (a) CBI apathy and CBI stereotypical behaviour, and (b) total DAD score at baseline. This model explained 67.8% of the variance of the annual rate of change in DAD scores (p < 0.01) ( table 3 ). In this model, apathy and stereotypical behaviours made a very small but significant contribution (2.3% variance), whereas 65.5% of the variance was explained by the functional score at baseline ( table 3 ) . ANOVA confirmed the statistical significance of this model (F (7) = 4.91, p < 0.05). The sequential addition of global cognitive scores or memory deficits did not change the model. Of note, everyday memory deficits did not factor as a significant predictor of annual rate of change in ADL for either svPPA or nfvPPA patients in any of the regression analyses. 
Discussion
This study demonstrated that decline (over a 12-month period) in ADL function can be largely predicted by cognitive scores in svPPA and a combination of behavioural and functional scores in nfvPPA. It also confirmed that both PPA subgroups maintain a mild degree of functional impairment in the initial 5 years of the disease, but present distinct profiles of behavioural changes. Patients with svPPA show marked stereotypical behaviour and apathy, but these do not seem to strongly predict functional decline. Baseline global cognitive score was found to be the strongest predictor of functional decline at follow-up for svPPA patients. Predictors of functional decline in nfvPPA, however, comprised a different model: a combination of baseline functional level, apathy and stereotypical behaviour. It is interesting that baseline total ADL score was a predictive factor of functional decline in nfvPPA but not in svPPA patients. Possible reasons include differences in disease stage at baseline between the two groups, or the well-described slower rate of disease progression in svPPA [8, 19] . In fact, different patterns of ADL decline have been described between nfvPPA and svPPA patient groups with matched disease duration [7] . Regardless of the reasons for the different predictors of functional decline for these groups, these dissimilar factors should be taken into account when planning intervention strategies. For instance, given baseline functional performance predicts functional decline in nfvPPA, addressing any functional limitations should be a focus of treatment when patients present at the clinic. For example, if a nfvPPA patient presents with impairments in initiating and planning their basic ADLs, a supportive intervention may include setting up the requirements for an activity and assisting the person to sequence through the steps of the activity with verbal prompting.
Our finding that a combination of behavioural and functional scores are the best predictors for functional decline in the nfvPPA group diverges from the Alzheimer's literature, where reports have identified cognitive and behavioural factors as the key predictors of ADL decline [20, 21] . A possible reason for this divergence is the use of different assessments in comparison to current published studies. Additionally, the discrepancy in factors predicting ADL decline in AD and FTD variants might be a reflection of dissimilar pathologies as well as differences in affected neuroanatomical areas. Indeed, our group of nfvPPA patients included 2/11 with apraxia of speech. It is possible that the inclusion of different forms of nfvPPA may have impacted on the results. Future studies should include a larger sample of nfvPPA patients to allow subtype analysis.
The identification of variables that do not contribute to functional decline is also critical in understanding changes over time. Behavioural changes are often evident at presentation in patients with svPPA, resembling behavioural variant FTD, but these behavioural changes do not seem to be relevant in predicting functional decline in svPPA. While marked behavioural changes are present in svPPA, they seem to somehow allow for continued participation in activities, albeit in a very rigid manner, instead of hindering their performance [22] [23] [24] . While there was a trend for global cognition to contribute to around a third of the variance in functional decline, the remaining factors which contribute to functional decline in svPPA remain unclear. The lack of behavioural factors contributing to ADL decline in the present study is, however, in contrast with a recent longitudinal study, which reported that increasing levels of apathy were correlated with declining ADL function in svPPA [24] . This is likely to be explained by the differences in methodological approach, i.e. cross-sectional and longitudinal. Another important consideration is the inclusion of 3/18 patients who had predominantly right-sided temporal lobe atrophy. For patients in the earlier stages of disease, this may have impacted on their clinical presentation, with right-sided patients exhibiting worse behavioural symptoms than patients with predominantly left-sided temporal lobe atrophy. With progression, however, the clinical profile of these subtypes becomes similar as left-sided svPPA also exhibit behavioural symptoms [25, 26] . Paradoxically, semantic deficits appear not to be a main contributing factor to functional decline, given that they appear very early in the disease and at a time when ADL function is very well preserved. The investigation of other factors affecting function in svPPA deserves future studies.
The differences in behavioural changes in svPPA and nfvPPA are noteworthy and raise two critical points [27] [28] [29] [30] [31] [32] . Firstly, people with svPPA have marked behavioural dysfunction, which at present, is overshadowed by the emphasis on the semantic deficits that characterize the syndrome. These marked behavioural changes are not part of the current diagnostic criteria but in many instances are of greater concern and distress to families than the wellreported semantic deficits [33] . Secondly, people with nfvPPA also demonstrate mildmoderate degrees of behavioural changes, such as apathy, which are equally underreported [30, 34] . A proportion of the nfvPPA group with behavioural changes in the present study later developed an atypical Parkinsonian syndrome (CBS or PSP) as a secondary condition [35] [36] [37] . Although less severe than in svPPA, the behavioural changes observed in nfvPPA should be closely monitored for better disease management and prognosis. Interestingly, a recent paper reported no differences in levels of apathy between svPPA and nfvPPA groups [38] . This is likely to be explained by the use of different assessment tools; the CBI-R has been shown to be highly sensitive to behavioural changes in the FTD spectrum [39] .
The present study also confirmed that functional abilities remain virtually intact for most PPA patients up to 5 years from disease onset, while behavioural changes are present from an early stage, most notably in svPPA. These findings reinforce the notion that assessment and monitoring of deficits in PPA should include a combination of tools measuring functional, behavioural, and cognitive deficits for a global and accurate characterization of impairments in PPA and care management [40, 41] .
The nfvPPA group had circumscribed length of symptoms, which impeded a comparative analysis between both PPA groups in the later stages of the disease (those with longer history of symptoms). It is possible that the results of this study may have been different if the nfvPPA group had a 5-year disease duration similar to the svPPA group. In fact, a study comparing the rate of functional decline between FTD variants found that nfvPPA patients who had an average disease duration of 5 years declined faster than an svPPA group with a similar disease duration [7] . Future studies should investigate predictors of functional decline in PPA subgroups with matched disease durations. Nonetheless, this shorter disease duration is of clinical relevance in itself, and a number of reasons could explain this difference in PPA group composition. The most plausible reason is that nfvPPA leads to a more aggressive disease progression [8] , and patients are not referred to research centres later in the disease course. This pattern of shorter time from disease onset to presentation for assessment in nfvPPA has been previously reported [35, 42] . Further, it is possible that in the earlier stages of disease the non-fluent language impairments are more obviously disruptive than the anomia seen in svPPA, so patients with nfvPPA are brought in for diagnosis sooner. Alternatively, by the time people with nfvPPA have a longer disease history (beyond 5 years), they might have developed additional symptoms that lead to a revised diagnosis of atypical Parkinsonian syndrome (CBS or PSP) [43] . Indeed, this occurred in a proportion (18%) of nfvPPA patients in this study.
Some limitations in this study include the relatively small sample size [44] , which was related to the need to restrict to participants who had complete data at the follow-up visits. Still, this sample size is in line with other published longitudinal studies in PPA. Another potential limitation is the use of proxy reporting measures to assess ADL function and behavioural symptoms, which may increase the likelihood of response bias in the data [45, 46] . Assessment by proxy, however, is the most common approach used in dementia studies.
In summary, this study demonstrated that functional profiles in svPPA and nfvPPA are rather similar in people with up to 5 years of disease duration. Behavioural changes are very marked in svPPA but do not predict the annual rate of change in disability; instead, global cognitive scores at baseline do. Despite the less marked nature of behavioural changes in nfvPPA, they make a significant contribution to functional disability, with functional scores at baseline making the strongest contribution to functional decline in nfvPPA. The dissimilar
